Cytosorbents Corp Azioni (CTSO) Dati Finanziari
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|---|
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues | 8.68%9.63 | 8.86 | 9.23 | 9.49 | 9.62 |
| Cost Of Revenue | 5.49%2.58 | 2.73 | 2.43 | 2.82 | 2.80 |
| Gross Profit | 14.99%7.05 | 6.13 | 6.80 | 6.67 | 6.81 |
5.59%9.69 | 9.17 | 11.19 | 9.53 | 10.43 | |
| Selling, General, and Administrative | 2.27%7.96 | 8.15 | 9.44 | 8.61 | 9.17 |
| Research and Development | 41.76%1.45 | 1.03 | - | - | - |
| Operating Income/Loss | 13.34%-2.64 | -3.04 | -4.39 | -2.86 | -3.62 |
| Nonoperating Income/Loss | 14.68%-1.78 | -2.09 | -1.11 | -0.71 | 5.56 |
| Income Tax Expense/Benefit, Current | - | - | - | - | - |
| Income Tax Expense/Benefit | - | - | - | -0.40 | - |
13.88%-4.42 | -5.13 | -5.50 | -3.17 | 1.95 | |
| Attributable To Parent | 13.88%-4.42 | -5.13 | -5.50 | -3.17 | 1.95 |
| Available To Common Stockholders, Basic | 13.88%-4.42 | -5.13 | -5.50 | -3.17 | 1.95 |
| Basic Average Shares | 0.11%62.81 | 62.74 | - | 62.75 | 62.61 |
| Diluted Average Shares | 0.11%62.81 | 62.74 | - | 62.75 | 67.17 |
| Basic Earnings Per Share | 12.50%-0.07 | -0.08 | - | -0.05 | 0.03 |
| Diluted Earnings Per Share | 12.50%-0.07 | -0.08 | - | -0.05 | 0.03 |